Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks
Clinical trial NCT02582996 · SUSPENDED
Trial details
- NCT number
- NCT02582996
- Sponsor
- Ache Laboratorios Farmaceuticos S.A.
- Status
- SUSPENDED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2021-04-01
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.